$3.15
0.00% day before yesterday
Nasdaq, Jul 11, 10:07 pm CET
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Theratechnologies Inc. Stock price

$3.15
+0.60 23.53% 1M
+1.49 89.76% 6M
+1.34 74.03% YTD
+1.70 117.24% 1Y
-4.93 61.01% 3Y
-5.57 63.88% 5Y
-3.25 50.78% 10Y
-2.43 43.56% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
+0.00 0.00%
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Key metrics

Basic
Market capitalization
$144.7m
Enterprise Value
$190.7m
Net debt
$46.0m
Cash
$4.3m
Shares outstanding
46.0m
Valuation (TTM | estimate)
P/E
negative | 36.7
P/S
1.6 | 1.7
EV/Sales
2.2 | 2.2
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-47.4%
Return on Equity
32.9%
ROCE
57.8%
ROIC
140.6%
Debt/Equity
-2.1
Financials (TTM | estimate)
Revenue
$88.7m | $84.8m
EBITDA
$15.1m | $12.4m
EBIT
$12.3m | $11.2m
Net Income
$-3.7m | $4.0m
Free Cash Flow
$-17.3m
Growth (TTM | estimate)
Revenue
13.5% | -1.3%
EBITDA
429.3% | 28.6%
EBIT
264.9% | 36.8%
Net Income
79.4% | 147.5%
Free Cash Flow
-206.0%
Margin (TTM | estimate)
Gross
79.0%
EBITDA
17.0% | 14.6%
EBIT
13.9%
Net
-4.2% | 4.7%
Free Cash Flow
-19.5%
More
EPS
$-0.1
FCF per Share
$-0.4
Short interest
0.8%
Employees
103
Rev per Employee
$830.0k
Show more

Is Theratechnologies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Theratechnologies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Theratechnologies Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Theratechnologies Inc. forecast:

Buy
90%
Hold
10%

Financial data from Theratechnologies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Feb '25
+/-
%
89 89
14% 14%
100%
- Direct Costs 19 19
8% 8%
21%
70 70
21% 21%
79%
- Selling and Administrative Expenses 42 42
2% 2%
47%
- Research and Development Expense 16 16
35% 35%
18%
15 15
429% 429%
17%
- Depreciation and Amortization 2.74 2.74
5% 5%
3%
EBIT (Operating Income) EBIT 12 12
265% 265%
14%
Net Profit -3.71 -3.71
79% 79%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Theratechnologies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Theratechnologies Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
MONTREAL, July 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today reported business highlights and financial results for the second quarter 2025, ended May 31, 2025. All figures are in U.S. dollars unless otherwise stated.
Neutral
GlobeNewsWire
9 days ago
MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.
Neutral
GlobeNewsWire
10 days ago
MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and...
More Theratechnologies Inc. News

Company Profile

Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Head office Canada
CEO Paul Lévesque
Employees 103
Founded 1993
Website www.theratech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today